the host
Fourteen years ago this week, the Affordable Care Act was signed into law, and Health and Human Services Secretary Xavier Becerra appeared on this week’s “What the Health?” with KFF Health News’ Julie Rovner. In this podcast, we discuss our accomplishments and the challenges that remain in health care law.
Meanwhile, Congress appears on track to finalize a fiscal year 2024 spending bill that includes funding for HHS, while eliminating many of the reproductive and gender-affirming health care regulations sought by Republicans. appear.
This week’s panelists are Julie Rovner of KFF Health News, Mary Agnes Carey of KFF Health News, Tami Luby of CNN, and Alice Miranda Olstein of Politico.
Here are our takeaways from this week’s episode.
- The Supreme Court is scheduled to hear oral arguments next week in a case that will determine whether the abortion drug mifepristone will remain readily available. The case itself deals with national restrictions rather than outright bans. But depending on the court’s decision, it could have far-reaching consequences, including, for example, people not being able to receive pills in the mail or limiting how long treatments can be used before pregnancy.
- This case is about more than abortion. Pharmaceutical companies and medical groups are concerned that the courts will set precedents that will supersede the FDA’s decisions regarding drug approvals.
- Ballot questions related to abortion are being asked in several states. The total number will ultimately depend on the success of citizen-led efforts to collect signatures to secure slots. These efforts face opposition from anti-abortion groups and elected officials who don’t want the question to reach the ballot box. Their concern, based on precedent, is that abortion protections are more likely to pass.
- The Biden administration issued an executive order this week to strengthen research on women’s health across the federal government. It includes several elements, including provisions aimed at increasing research into illnesses and illnesses related to postmenopausal women. It also aims to increase the number of women participating in clinical trials.
- Medical Misinformation of the Week: The Supreme Court hears oral arguments in this case. Marcy vs. Missouri. The problem is that Biden administration officials overstepped their authority when they asked companies like Meta, Google, and X to remove or downgrade content that was flagged as COVID-19 misinformation. The question is whether or not.
Plus, for “extra credit,” our panelists will suggest health policy articles they read this week that they think you should read, too.
Julie Rovner: The Washington Post’sArizona lawmaker tells abortion story to show ‘reality’ of regulation, by Praveena Somasundaram. (Full text of speech here. )
Alice Miranda Olstein: CNN’s “Why is your clinic sending you tons of appointment reminders?” by Nathaniel Meyersohn.
Tami Luby: “Georgia’s Medicaid work requirement costs taxpayers millions of dollars despite low enrollment” by Andy Miller and Renuka Rayasam of KFF Health News.
Mary Agnes Carey: New York Times’When Medicaid applies after the family homeby Paula Spann, Associated Press “State Medicaid office targets dead people’s homes to recover medical costswritten by Amanda Seitz.
Also mentioned in this week’s podcast:
To listen to all podcasts, go to click here.
Subscribe to KFF Health News’ What the Health?upon spotify, apple podcast, pocket castor wherever you listen to podcasts.
